期刊文献+

急性脑梗死患者血小板α颗粒功能变化及口服阿司匹林的疗效观察 被引量:2

The function changes of platelet at acute cerebral infarct patients and investigated for orally low-dose aspirin therapy
下载PDF
导出
摘要 目的对比观察急性脑梗死患者血小板α颗粒功能变化 ,及口服不同剂量阿司匹林的临床效果。方法 6 7例急性脑梗死患者随机分为对照组 (n =2 2 )、试验 1组 (n =2 3)和试验 2组 (n =2 2 ) ,试验组入院后当天开始口服阿司匹林 ,试验 1组 1 5 0mg/d ,试验 2组 30 0mg/d ;对照组则口服安慰剂 ,连续 1 4d ,于治疗前、治疗后 3d、7d和 1 4d检测血浆血小板α颗粒膜蛋白 1 4 0 (GMP 1 4 0 )、β -血小板球蛋白 (β TG)和血小板因子 4 (PF4)。结果三组患者治疗前、治疗后 3d上述参数比较差异无显著意义 (P >0 .0 5 ) ;入院后 7d和 1 4d ,上述参数比较差异有显著意义 (P <0 .0 5或P <0 .0 1 ) ,且试验 2组明显低于试验 1组 (P <0 .0 5 )。结论急性脑梗死患者血小板处于激活状态 ,其释放功能增强 ,阿司匹林有减轻其释放的作用 。 Objective To evaluate the effects of orally low-dose aspirin therapy at acute cerebral infarct patients and investigate the function changes of platelet. Methods 67 cases with acute cerebral patients were divided into test group I, test group II and control group, The test group I was applied aspirin therapy (150mg/d) and the test group II was applied 300mg/d, placebo was applied in the control group, The blood plasma platelet granular membrane protein 140(GMP 140), β thromboglobulin(β TG) and platelet factor 4(PF4) were measured on different time. Results The changes of GMP 140, β TG and PF4 in three groups have no different before treat and 3 day after treat with aspirin, but there were significantly less in test groups than those in the control group ( P <0.05 or P <0.01) on 7 day, 14 day after treat with aspirin. Furthermore, there were significantly different between the test groups( P <0.05). Conclusion The function of platelet has a great change at acute cerebral infarct patients and take orally low-dose aspirin therapy has a better effect certainly.
出处 《贵州医药》 CAS 2003年第8期698-700,共3页 Guizhou Medical Journal
关键词 急性脑梗死 血小板 α颗粒 阿司匹林 Cerebral infarct Platelet function Aspirin
  • 相关文献

参考文献9

  • 1Faymonville ME, Deby--Dupont G, Larbuisson R,et al.Prostaglandin E2, prostacyclin , and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg, 1986,91 : 858-866.
  • 2Berge E, Sandercock P. Anticoagulants versus antiplatelet agents for acute ischaemic stroke. Cochrane Database Syst Rev, 2002, (4) : CD003242.
  • 3Akaike M, Azuma H, Kagawa A,et al. Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases. Clin Chem, 2002 ,48(9) : 1454-1459.
  • 4De Cristobal J, Moro MA, Davalos A,et al . Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats. J Neurochem, 2001,79(2) : 456-459.
  • 5Cubillana Herrero JD, Soler Valcarcel A, Albaladejo Devis I, et al. Susac syndrome as a cause of sensorineural hearing loss. Acta Otorrinolaringol Esp, 2002 , 53 (5) :379-383.
  • 6Tanahashi N. Antithrombotic therapy in cerebral infarction, Rinsho Shinkeigaku, 2000,40 (12) :1251 - 1253.
  • 7Chowdhury A, Ganguly G, Chowdhury D, et al. Gastro--duodenal mucosal changes associated with low--dose aspirin therapy: a prospective, endoscopic study. Indian J Gastroenterol, 2001, 20(6) : 227-229.
  • 8Matias--Guiu J, Ferro JM, Alvarez--Sabin J, et al.Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-- blind, multicenter trial. Stroke,2003,34(4) :840-848.
  • 9Pinsky DJ, Broekman M J, Peschon JJ,et al. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest, 2002,109(8) : 1031-1040.

同被引文献15

  • 1蔡建,黄流清,赵忠新.脑卒中二级预防的药物应用[J].国外医学(神经病学.神经外科学分册),2004,31(3):276-279. 被引量:2
  • 2刘洁,罗永杰,余能伟,韦永胜,杨友松.多灶性脑梗死患者血浆血小板4因子变化及其临床意义[J].临床神经病学杂志,2004,17(4):289-290. 被引量:21
  • 3张仁岗,张军平.阿司匹林抵抗的产生机制与防治策略[J].中西医结合学报,2007,5(3):259-262. 被引量:9
  • 4Buyukasik Y,Soylu B,Soylu AR,et al.In vivo Platelet and T-lymPhocyte activites during Pulmonary tubereulosis.Eur ResPir J,1998,12(6):1375-1379.
  • 5罗永杰 韦永胜 刘洁 等.血小板4因子在急性脑梗死中的动态作用[J].中国医药指南,2005,3(13):1645-1647.
  • 6Ghaddar HM,Cortes J,Salomaa V,et al.Correlation of sPecific Platelet activation markers with caroticl arterial wall thickness.Thromb Haemostas,1995,74(3):943-948.
  • 7Laghrissi-Thode F,Wagner WR,Pollock BG,et al.Elevated Platelet factor 4 and beta-thromboglobulin Plasma levels in de Pressed Patients with ischemic heart disease.Biol Psychiatry,1997,42(4):290-295.
  • 8ADERIBIGBE AO,EMUDIANUGHE TS,LAWAL BA.Evaluationof the antidia Betic action of Manfiferin indica in mice. PhytotherRes . 2001
  • 9Christine S.Rinder,Laura A.Student,Jayne L.Bonan,etc.Aapirin Does Not Inhibit Adenosine Diphosphate-induced Platelet α -Granule Release. Blood . 1993
  • 10Kaplan KL,Owen J.Plasma levels ofβ-thromboglobulin and platelet factor 4 as indicators of platelet activation in vivo〔J〕. Blood . 2003

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部